Literature DB >> 6694078

Mechanism of freeze-thaw instability of aluminum hydroxycarbonate and magnesium hydroxide gels.

M I Zapata, J R Feldkamp, G E Peck, J L White, S L Hem.   

Abstract

The effect of freeze-thaw cycles on the physical stability of aluminum hydroxycarbonate and magnesium hydroxide gels was studied. Coagulation following a freeze-thaw cycle, leading to the formation of visible aggregates, affected the content uniformity of both gels. The freeze-thaw cycles did not affect the crystal form or surface characteristics of the gels as determined by X-ray powder diffraction and point of zero charge, but caused a slight reduction in the rate of acid neutralization and a large increase in the rate of sedimentation. The greatest effect was observed after the first freeze-thaw cycle. While the duration of freezing was not a factor, the rate of freezing was important and was inversely related to the aggregate size. The aggregates which formed following a freeze-thaw cycle were not redispersed by shaking, but were reversed by ultrasonic treatment or homogenization. The adsorption of polymers or surface-active agents prior to freezing reduced and, in some cases, prevented the formation of aggregates. The physical instability produced by a freeze-thaw cycle was explained by the modified DLVO theory. The force exerted on the particles by the growing ice crystals forced the particles into the primary minimum, producing strong interparticle attraction. On thawing, simple agitation did not provide enough force to overcome the attractive force of the primary minimum. Adsorption of polymers or surface-active agents increased the steric repulsive force and prevented the particles from reaching the primary minimum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6694078     DOI: 10.1002/jps.2600730103

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application.

Authors:  Yuh-Fun Maa; Mahmoud Ameri; Robert Rigney; Lendon G Payne; Dexiang Chen
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

2.  Development of a highly thermostable, adjuvanted human papillomavirus vaccine.

Authors:  Kimberly J Hassett; Natalie M Meinerz; Florian Semmelmann; Megan C Cousins; Robert L Garcea; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2015-05-18       Impact factor: 5.571

3.  A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.

Authors:  Xinran Li; Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  J Control Release       Date:  2015-02-28       Impact factor: 9.776

4.  The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.

Authors:  Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-01-04       Impact factor: 3.452

5.  Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.

Authors:  Kimberly J Hassett; Megan C Cousins; Lilia A Rabia; Chrystal M Chadwick; Joanne M O'Hara; Pradyot Nandi; Robert N Brey; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2013-04-10       Impact factor: 5.571

6.  Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide.

Authors:  Carly Fleagle Chisholm; Taek Jin Kang; Miao Dong; Kasey Lewis; Madhuri Namekar; Axel T Lehrer; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2019-01-28       Impact factor: 5.571

7.  Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization.

Authors:  Yuh-Fun Maa; Cassandra Shu; Mahmoud Ameri; Cindy Zuleger; Jenny Che; Jorge E Osorio; Lendon G Payne; Dexiang Chen
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

Review 8.  Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.

Authors:  Tanya Clapp; Paul Siebert; Dexiang Chen; LaToya Jones Braun
Journal:  J Pharm Sci       Date:  2010-08-25       Impact factor: 3.534

9.  A polymer/oil based nanovaccine as a single-dose immunization approach.

Authors:  Sara Vicente; Belen Diaz-Freitas; Mercedes Peleteiro; Alejandro Sanchez; David W Pascual; Africa Gonzalez-Fernandez; Maria J Alonso
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

10.  Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures.

Authors:  Juliette Fortpied; Florence Wauters; Christelle Rochart; Philippe Hermand; Bernard Hoet; Nicolas Moniotte; Ivo Vojtek
Journal:  Hum Vaccin Immunother       Date:  2018-02-12       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.